{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:28:47Z","timestamp":1791264527252,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.canlet.2009.01.011","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T05:52:28Z","timestamp":1233985948000},"page":"10-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Mechanism of bone metastasis: The role of osteoprotegerin and of the host-tissue microenvironment-related survival factors"],"prefix":"10.1016","volume":"283","author":[{"given":"Sofia","family":"Fili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Karalaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2009.01.011_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/CS20050175","article-title":"Role of osteoprotegerin (OPG) in cancer","volume":"110","author":"Holen","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.canlet.2009.01.011_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.canlet.2009.01.011_bib3","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK System","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2009.01.011_bib4","doi-asserted-by":"crossref","first-page":"iii81","DOI":"10.1136\/ard.60.90003.iii81","article-title":"Osteoprotegerin","volume":"60","author":"Feige","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.canlet.2009.01.011_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5507\/bp.2001.013","article-title":"Osteoprotegerin, RANK, RANKL","volume":"145","author":"Stejskal","year":"2001","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech Repub."},{"key":"10.1016\/j.canlet.2009.01.011_bib6","first-page":"844","article-title":"The osteoprotegerin\/osteoprotegerin ligand family: role in inflammation and bone loss","volume":"31","author":"Yeung","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.canlet.2009.01.011_bib7","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2009.01.011_bib9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2009.01.011_bib10","series-title":"Medical Physiology: A Cellular and Molecular Approach","first-page":"1413","article-title":"Bone physiology","author":"Boron","year":"2006"},{"key":"10.1016\/j.canlet.2009.01.011_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.spinee.2005.06.009","article-title":"Intradural, extramedullarly spinal sarcoidosis: report of a rare case and review of the literature","volume":"6","author":"Schaller","year":"2006","journal-title":"Spine J."},{"key":"10.1016\/j.canlet.2009.01.011_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-005-1469-4","article-title":"Spinal meningioma: relationship between histological subtypes and surgical outcome?","volume":"75","author":"Schaller","year":"2005","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.canlet.2009.01.011_bib13","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/en.2005-1502","article-title":"Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8","volume":"47","author":"Valta","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2009.01.011_bib14","series-title":"Principles of Bone Biology","first-page":"825","article-title":"Fibroblast growth factor (FGF) and FGF receptor families in bone","author":"Hurley","year":"2002"},{"key":"10.1016\/j.canlet.2009.01.011_bib15","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1359\/jbmr.2001.16.11.2074","volume":"16","author":"Chikazu","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib16","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-\u03baB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib17","series-title":"Bone Metastasis","first-page":"125","article-title":"Role of interleukin-11 in osteolytic bone metastasis","author":"Simon","year":"2005"},{"key":"10.1016\/j.canlet.2009.01.011_bib18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1177\/00220345990780100601","article-title":"Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha","volume":"78","author":"Tani-Ishii","year":"1999","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI4682","article-title":"Estrogen\u2019s bone protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells","volume":"103","author":"Sunyer","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2009.01.011_bib20","first-page":"269","article-title":"Effects of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 on the release of collagenase and gelatinase from osteoblasts","volume":"6","author":"Eun","year":"2002","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.canlet.2009.01.011_bib21","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-\u03baB ligand, osteoprotegerin and receptor activator of NF-\u03baB in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2009.01.011_bib22","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood-2003-10-3438","article-title":"Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support","volume":"103","author":"Rodriguez","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2009.01.011_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/me.2006-0346","article-title":"Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation","volume":"21","author":"Clines","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.canlet.2009.01.011_bib24","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/bjc.1998.397","article-title":"Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: a unique case report and review of the literature","volume":"77","author":"Schaller","year":"1998","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis","volume":"80","author":"Mundy","year":"1997","journal-title":"Cancer Suppl."},{"key":"10.1016\/j.canlet.2009.01.011_bib26","series-title":"Pathology","author":"B\u00f6cker","year":"2007"},{"key":"10.1016\/j.canlet.2009.01.011_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1359\/jbmr.2003.18.2.190","article-title":"Mechanisms of tumor metastasis to the bone: challenges and opportunities","volume":"18","author":"Reddi","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib28","first-page":"269","article-title":"Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis","volume":"t86","author":"Neville-Webbe","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2009.01.011_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib30","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","article-title":"Molecular mechanisms of osteolytic bone metastases","volume":"88","author":"Guisse","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","article-title":"Mechanisms of osteolytic bone metastases in breast carcinoma","volume":"97","author":"K\u00e4k\u00f6nen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib32","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guisse","year":"2006","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib33","first-page":"1619","article-title":"Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells","volume":"62","author":"Holen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer induced osteoclastogenesis and prevents tumor growth in the bone","volume":"107","author":"Zhang","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2009.01.011_bib35","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1158\/1535-7163.MCT-08-0046","article-title":"RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis","volume":"7","author":"Miller","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2009.01.011_bib36","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-04-2033","article-title":"Osteoprotegerin in prostate cancer bone metastases","volume":"65","author":"Corey","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib37","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1359\/JBMR.040703","article-title":"Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis","volume":"19","author":"Nyambo","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0090-4295(00)01122-5","article-title":"Osteoprotegerin and rank ligand expression in prostate cancer","volume":"57","author":"Brown","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2009.01.011_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cncr.21978","article-title":"Expression of RANK\/RANKL\/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation","volume":"107","author":"Chen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib40","unstructured":"T. Guise, B.G. Grubbs, Y. Cuo, J.R. Wu-Wong, J. Wessale, R.J. Padley, Endothelin A receptor blockade inhibits osteoblastic metastases, ASCO Annual Meeting, 2001"},{"key":"10.1016\/j.canlet.2009.01.011_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3346\/jkms.2003.18.4.541","article-title":"Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis","volume":"18","author":"Park","year":"2003","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.canlet.2009.01.011_bib42","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2009.01.011_bib43","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0002-9440(10)63560-2","article-title":"Receptor activator of nuclear factor kB ligand (RANKL)\/osteoprotegerin (OPG) ratio is increased in severe osteolysis","volume":"163","author":"Grimaud","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2009.01.011_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jcb.21382","article-title":"Osteoprotegrin and the bone homing and colonization potential of breast cancer cells","volume":"103","author":"Kapor","year":"2008","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.canlet.2009.01.011_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10585-007-9127-1","article-title":"Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis","volume":"25","author":"Canon","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2009.01.011_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-005-2419-8","article-title":"Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo \u2013 a role in tumour cell survival?","volume":"92","author":"Holen","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2009.01.011_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2005.01.059","article-title":"Mechanisms of bone invasion and metastasis in human neuroblastoma","volume":"228","author":"Sohara","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2009.01.011_bib48","first-page":"324","article-title":"Bone metastases in lung cancer: the role of bisphonates","volume":"19","author":"Marketos","year":"2006","journal-title":"Pneumonia"},{"key":"10.1016\/j.canlet.2009.01.011_bib49","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.juro.2006.06.028","article-title":"Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma","volume":"176","author":"Jung","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2009.01.011_bib50","series-title":"Thyroid Cancer","author":"Hodak","year":"2006"},{"key":"10.1016\/j.canlet.2009.01.011_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.regpep.2008.02.004","article-title":"OPG, RANK and RANK ligand expression in thyroid lesions","volume":"148","author":"Heymann","year":"2008","journal-title":"Regul. Peptides"},{"key":"10.1016\/j.canlet.2009.01.011_bib52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00428-003-0845-8","article-title":"Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma","volume":"443","author":"Ito","year":"2003","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2009.01.011_bib53","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1158\/1078-0432.CCR-07-5019","article-title":"OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer","volume":"14","author":"De Toni","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0959-8049(00)00436-6","article-title":"Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines","volume":"37","author":"Perez","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2009.01.011_bib56","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.20550","article-title":"Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma","volume":"101","author":"Mizutani","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12026-007-0084-1","article-title":"Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer","volume":"39","author":"Simons","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2009.01.011_bib59","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1517\/14656566.9.6.937","article-title":"Pharmacotherapy of bone metastases in breast cancer patients","volume":"9","author":"Petrut","year":"2008","journal-title":"Expert Opin. Pharmacotherap."},{"key":"10.1016\/j.canlet.2009.01.011_bib60","first-page":"49","article-title":"RANKL\/RANK\/OPG: new therapeutic targets in bone tumours and associated osteolysis","volume":"1704","author":"Wittrant","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2009.01.011_bib61","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007 a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.01.011_bib62","first-page":"604","article-title":"Technology evaluation: denosumab, amgen","volume":"7","author":"Abrahamsen","year":"2005","journal-title":"Curr. Opin. Mol. Therap."},{"key":"10.1016\/j.canlet.2009.01.011_bib63","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1078-0432.CCR-05-1933","article-title":"A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer","volume":"12","author":"Body","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.01.011_bib64","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jps.20676","article-title":"Cell adhesion molecules for targeted drug delivery","volume":"95","author":"Dunehoo","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.canlet.2009.01.011_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1479-5876-2-16","article-title":"Endothelin receptors as novel targets in tumor therapy","volume":"2","author":"Bagnato","year":"2004","journal-title":"J. Trans. Med."},{"key":"10.1016\/j.canlet.2009.01.011_bib66","first-page":"146","article-title":"The role of endothelin in stroke: experimental data and underlying pathophysiology","volume":"2","author":"Schaller","year":"2006","journal-title":"Arch. Med. Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:29:00Z","timestamp":1759591740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383509000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0304383509000263"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2009.01.011","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of bone metastasis: The role of osteoprotegerin and of the host-tissue microenvironment-related survival factors","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2009.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}